EP 2654787 A1 20131030 - MODIFIED INFLUENZA HEMAGGLUTININ PROTEINS AND USES THEREOF
Title (en)
MODIFIED INFLUENZA HEMAGGLUTININ PROTEINS AND USES THEREOF
Title (de)
MODIFIZIERTE INFLUENZA-HÄMAGGLUTININ-PROTEINE UND VERWENDUNGEN DAVON
Title (fr)
PROTÉINES DE TYPE HÉMAGGLUTININE DU VIRUS DE LA GRIPPE MODIFIÉES ET LEURS UTILISATIONS
Publication
Application
Priority
- US 201061426390 P 20101222
- US 2011066867 W 20111222
Abstract (en)
[origin: WO2012088428A1] The present invention is generally directed to modified influenza hemagglutinin (HA) proteins and methods for making and using them, including their use in immunogenic compositions such as vaccines for the treatment and/or prevention of influenza infection.
IPC 8 full level
A61K 39/145 (2006.01); C12N 15/44 (2006.01)
CPC (source: EP KR)
A61K 39/145 (2013.01 - KR); A61P 31/16 (2018.01 - EP); A61P 37/04 (2018.01 - EP); C12N 7/00 (2013.01 - EP KR); C12N 15/11 (2013.01 - KR); A61K 39/00 (2013.01 - EP KR); A61K 2039/5258 (2013.01 - EP); C12N 2760/16122 (2013.01 - EP); C12N 2760/16123 (2013.01 - EP); C12N 2760/16134 (2013.01 - EP); C12N 2799/026 (2013.01 - EP)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2012088428 A1 20120628; AU 2011348160 A1 20130404; BR 112013016239 A2 20161122; CA 2822443 A1 20120628; CN 103384531 A 20131106; EP 2654787 A1 20131030; JP 2014505681 A 20140306; KR 20140021530 A 20140220; MX 2013007255 A 20130926; SG 191295 A1 20130731
DOCDB simple family (application)
US 2011066867 W 20111222; AU 2011348160 A 20111222; BR 112013016239 A 20111222; CA 2822443 A 20111222; CN 201180068254 A 20111222; EP 11849944 A 20111222; JP 2013546424 A 20111222; KR 20137018879 A 20111222; MX 2013007255 A 20111222; SG 2013048137 A 20111222